Literature DB >> 16865547

MMR-vaccine and regression in autism spectrum disorders: negative results presented from Japan.

Tokio Uchiyama1, Michiko Kurosawa, Yutaka Inaba.   

Abstract

It has been suggested that the measles, mumps, and rubella vaccine (MMR) is a cause of regressive autism. As MMR was used in Japan only between 1989 and 1993, this time period affords a natural experiment to examine this hypothesis. Data on 904 patients with autism spectrum disorders (ASD) were analyzed. During the period of MMR usage no significant difference was found in the incidence of regression between MMR-vaccinated children and non-vaccinated children. Among the proportion and incidence of regression across the three MMR-program-related periods (before, during and after MMR usage), no significant difference was found between those who had received MMR and those who had not. Moreover, the incidence of regression did not change significantly across the three periods.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 16865547     DOI: 10.1007/s10803-006-0157-3

Source DB:  PubMed          Journal:  J Autism Dev Disord        ISSN: 0162-3257


  13 in total

1.  Autism and infection/immunization episodes in Japan.

Authors:  H Takahashi; S Arai; K Tanaka-Taya; N Okabe
Journal:  Jpn J Infect Dis       Date:  2001-04       Impact factor: 1.362

2.  No evidence for a new variant of measles-mumps-rubella-induced autism.

Authors:  E Fombonne; S Chakrabarti
Journal:  Pediatrics       Date:  2001-10       Impact factor: 7.124

3.  Neurologic disorders after measles-mumps-rubella vaccination.

Authors:  Annamari Mäkelä; J Pekka Nuorti; Heikki Peltola
Journal:  Pediatrics       Date:  2002-11       Impact factor: 7.124

4.  A population-based study of measles, mumps, and rubella vaccination and autism.

Authors:  Kreesten Meldgaard Madsen; Anders Hviid; Mogens Vestergaard; Diana Schendel; Jan Wohlfahrt; Poul Thorsen; Jørn Olsen; Mads Melbye
Journal:  N Engl J Med       Date:  2002-11-07       Impact factor: 91.245

5.  Aseptic meningitis as a complication of mumps vaccination.

Authors:  A Sugiura; A Yamada
Journal:  Pediatr Infect Dis J       Date:  1991-03       Impact factor: 2.129

6.  Regression in pervasive developmental disorders: seizures and epileptiform electroencephalogram correlates.

Authors:  R F Tuchman; I Rapin
Journal:  Pediatrics       Date:  1997-04       Impact factor: 7.124

7.  Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: population study.

Authors:  Brent Taylor; Elizabeth Miller; Raghu Lingam; Nick Andrews; Andrea Simmons; Julia Stowe
Journal:  BMJ       Date:  2002-02-16

8.  Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association.

Authors:  B Taylor; E Miller; C P Farrington; M C Petropoulos; I Favot-Mayaud; J Li; P A Waight
Journal:  Lancet       Date:  1999-06-12       Impact factor: 79.321

9.  An epidemiological study on Japanese autism concerning routine childhood immunization history.

Authors:  Hiroshi Takahashi; Shynsuke Suzumura; Fumiko Shirakizawa; Noriyuki Wada; Keiko Tanaka-Taya; Satoru Arai; Nobuhiko Okabe; Hironobu Ichikawa; Taizo Sato
Journal:  Jpn J Infect Dis       Date:  2003-06       Impact factor: 1.362

10.  Clinical features of autistic children with setback course in their infancy.

Authors:  Y Hoshino; M Kaneko; Y Yashima; H Kumashiro; F R Volkmar; D J Cohen
Journal:  Jpn J Psychiatry Neurol       Date:  1987-06
View more
  10 in total

1.  A surprising METamorphosis: autism genetics finds a common functional variant.

Authors:  Matthew W State
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-30       Impact factor: 11.205

Review 2.  Environmental factors associated with autism spectrum disorder: a scoping review for the years 2003-2013.

Authors:  M Ng; J G de Montigny; M Ofner; M T Do
Journal:  Health Promot Chronic Dis Prev Can       Date:  2017-01       Impact factor: 3.240

3.  Vaccine Hesitancy and Illness Perceptions: Comparing Parents of Children with Autism Spectrum Disorder to other Parent Groups.

Authors:  Leila C Sahni; Julie A Boom; Sarah S Mire; Leandra N Berry; Lauren R Dowell; Charles G Minard; Rachel M Cunningham; Robin P Goin-Kochel
Journal:  Child Health Care       Date:  2020-03-17

Review 4.  Pharmacoepidemiology: Using randomised control trials and observational studies in clinical decision-making.

Authors:  Thomas M Caparrotta; James W Dear; Helen M Colhoun; David J Webb
Journal:  Br J Clin Pharmacol       Date:  2019-07-24       Impact factor: 4.335

Review 5.  Vaccines for measles, mumps and rubella in children.

Authors:  Vittorio Demicheli; Alessandro Rivetti; Maria Grazia Debalini; Carlo Di Pietrantonj
Journal:  Cochrane Database Syst Rev       Date:  2012-02-15

Review 6.  Vaccines for measles, mumps, rubella, and varicella in children.

Authors:  Carlo Di Pietrantonj; Alessandro Rivetti; Pasquale Marchione; Maria Grazia Debalini; Vittorio Demicheli
Journal:  Cochrane Database Syst Rev       Date:  2021-11-22

Review 7.  Atypical antipsychotics in children with pervasive developmental disorders.

Authors:  Benjamin Chavez; Mapy Chavez-Brown; Michael A Sopko; Jose A Rey
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

8.  Vaccines for measles, mumps, rubella, and varicella in children.

Authors:  Carlo Di Pietrantonj; Alessandro Rivetti; Pasquale Marchione; Maria Grazia Debalini; Vittorio Demicheli
Journal:  Cochrane Database Syst Rev       Date:  2020-04-20

9.  Environmental risk factors for autism.

Authors:  Rodney R Dietert; Janice M Dietert; Jamie C Dewitt
Journal:  Emerg Health Threats J       Date:  2011-04-20

10.  Lack of association between measles virus vaccine and autism with enteropathy: a case-control study.

Authors:  Mady Hornig; Thomas Briese; Timothy Buie; Margaret L Bauman; Gregory Lauwers; Ulrike Siemetzki; Kimberly Hummel; Paul A Rota; William J Bellini; John J O'Leary; Orla Sheils; Errol Alden; Larry Pickering; W Ian Lipkin
Journal:  PLoS One       Date:  2008-09-04       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.